Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia
Trial details
- Registry ID
- NCT00254202
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute SchizophreniaNCT00254202 | Vanda Pharmaceuticals | Phase 3 | Completed | 2006-09-26Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |